Showing results (151-160 of 171) with videos related to

Sort By:
Pageof 18
Anticancer Research|February 27, 2026
Effectiveness of Pembrolizumab Monotherapy for Older Adults With Head and Neck Carcinoma by CPS StatusYuri Ueda, Takuro Okada, Isaku Okamoto, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 20, 2022
Establishment of experimental salivary gland cancer models using organoid culture and patient-derived xenograftingYoshihiro Aizawa, Kentaro Takada, Jun Aoyama, et al.
Anticancer Research|August 28, 2024
Role of Hematological Markers in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Treated With PembrolizumabKohei Hagiwara, Takashi Matsuki, Takuro Okada, et al.
The Oncologist|March 31, 2025
Clinical outcomes of recurrent or metastatic head and neck cancer after failure of platinum and nivolumab: a multicenter retrospective studyTakane Watanabe, Hiroki Oka, Kengo Nagashima, et al.
Asia-Pacific Journal of Clinical Oncology|September 8, 2025
Hematological Markers Predict Immune-Related Adverse Events in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Treated With PembrolizumabTakashi Matsuki, Takuro Okada, Chihiro Fushimi, et al.
Scientific Reports|October 13, 2020
Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinomaKazutomo Niwa, Daisuke Kawakita, Toshitaka Nagao, et al.
Anticancer Research|February 27, 2022
Comparison of Dosage of Nivolumab in Efficacy and Safety for Recurrent Metastatic Squamous Cell CarcinomaTakuro Okada, Chihiro Fushimi, Takashi Matsuki, et al.
Cancer Science|June 7, 2024
Human papillomavirus-driven head and neck cancers in Japan during 2008-2009 and 2018-2019: The BROADEN studyKen-Ichi Nibu, Nobuhiko Oridate, Yuki Saito, et al.
International Journal of Clinical Oncology|October 20, 2022
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048Shunji Takahashi, Nobuhiko Oridate, Kaoru Tanaka, et al.
Biochemical and Biophysical Research Communications|December 7, 2019
FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary glandYasuhiro Isono, Mitsuko Furuya, Tatsu Kuwahara, et al.
Pageof 18